May 24, 2013 – The U.S. Food & Drug Administration (FDA) issued a warning today stating that it is investigating at least seven adverse events in patients who received corticosteroid injections that were prepared by Main Street Family Pharmacy, LLC in Newbern, Tennessee. All seven patients were treated with preservative free methylprednisolone acetate (80 mg/mL) by injection. The clinical information concerning these reactions is still pending, but at least one of the infections appears to be fungal in nature.
Compounding Pharmacy Recall Update 8/12/13: Texas-based compounding pharmacy Specialty Compounding, LLC, has issued a nationwide recall for all lots of medications it has processed since May 9. To date, at least 15 people have been diagnosed with a rare bacterial infection after being administered injections of calcium gluconate at a pair of Texas hospitals. In response to this and a number of other recent compounding pharmacy recalls, the FDA is asking Congress for increased oversight and authority over these operations. Click here to learn more.
Free Methylprednisolone Acetate Lawsuit Evaluation: If you or a loved one suffered an adverse reaction after receiving a methylprednisolone acetate corticosteroid injection that you believe may have been processed by Main Street Family Pharmacy in Newbern, Tenn., you should contact our law firm immediately. You may be entitled to compensation by filing a suit against Main Street Family Pharmacy and we can help.
What’s the Problem?
According to today’s FDA press release, the investigation into the cause of the adverse reactions is ongoing, but is currently focused on potentially tainted vials of methylprednisolone acetate, a widely-prescribed corticosteroid hormone drug used for the treatment of pain and swelling that occurs in individuals suffering from arthritis and other joint disorders. The administration will continue to work with the Centers for Disease Control and Prevention (CDC) and state health authorities until the investigation into the source of the outbreak is complete. Until that time, the FDA is advising healthcare providers not to administer any products labeled as sterile from Main Street and take them out of circulation until further guidance is provided.
These events come less than a year after tainted vials of methylprednisolone acetate processed by the New England Compounding Center (NECC) were linked to 48 fungal meningitis deaths and more than 700 serious injuries. The fungal contamination was reportedly identified through routine testing conducted on one of the sealed vials taken from NECC’s plant in Framingham, Mass. The same fungus was found in a number of patients who were treated with methylprednisolone acetate, according to the FDA.
Do I Have a Methylprednisolone Acetate Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in methylprednisolone acetate lawsuits. We are handling individual litigation nationwide and currently accepting new methylprednisolone acetate adverse event cases in all 50 states.
Free Methylprednisolone Acetate Lawsuit Evaluation: If you or a loved one suffered an adverse reaction after receiving a methylprednisolone acetate corticosteroid injection that you believe may have been processed by Main Street Family Pharmacy in Newbern, Tenn., you should contact our law firm immediately. You may be entitled to compensation by filing a methylprednisolone acetate suit and we can help.